Investor Update
Basel, 31 July 2008
Toll Manufacturing Agreement for the Bulk Drug Substance of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody
Dear Investor,
Please find enclosed a press release by Chugai.
Basel, 31 July 2008
Dear Investor,
Please find enclosed a press release by Chugai.